- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Measuring Performance of Patient-Centered Outcomes Research
In 2017, the review of the Patient-Centered Outcomes Research Trust Fund will determine the adequacy and the use of funding and there are 3 ways to measure performance in patient-centered outcomes research.
In 2017, the review of the Patient-Centered Outcomes Research Trust Fund will determine the adequacy and the use of funding to determine whether levels should be adjusted in autumn 2019. And now researchers are analyzing work in patient-centered outcomes research to ascertain how well the work is being done and what might be done better, according to a new commentary from RAND.
The Patient-Centered Outcomes Research Institute, established in 2010, has funded hundreds of studies and Thomas W. Concannon, senior policy researcher at RAND, highlights 3 ways to measure performance in patient-centered outcomes research:
- Ongoing and public inventory to explain how trust fund dollars earmarked for patient-centered outcomes research have been spent
- Procedural assessments to examine whether investigators are getting the principles of patient centeredness right
- Evaluation of whether patient-centered outcomes research is making a difference to healthcare quality and outcomes
Read the full commentary at RAND.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
